533 related articles for article (PubMed ID: 28109882)
1. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
Baba MM; Ikusemoran M
Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
[TBL] [Abstract][Full Text] [Related]
2. Yellow fever: an emerging threat for Kenya and other east African countries.
Sanders EJ; Tukei PM
East Afr Med J; 1996 Jan; 73(1):10-2. PubMed ID: 8625854
[TBL] [Abstract][Full Text] [Related]
3. Yellow fever in the diagnostics laboratory.
Domingo C; Charrel RN; Schmidt-Chanasit J; Zeller H; Reusken C
Emerg Microbes Infect; 2018 Jul; 7(1):129. PubMed ID: 30002363
[TBL] [Abstract][Full Text] [Related]
4. Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa.
Uchenna Emeribe A; Nasir Abdullahi I; O R Ajagbe O; Egede Ugwu C; Oloche Onoja S; Dahiru Abubakar S; Modesta Umeozuru C; Sunday Animasaun O; Omoruyi Omosigho P; Mukhtar Danmusa U; Alhaji Baba Mallam M; Saidu Aminu M; Yahaya H; Oyewusi S
Pathog Dis; 2021 Apr; 79(4):. PubMed ID: 33739369
[TBL] [Abstract][Full Text] [Related]
5. The enigma of yellow fever in East Africa.
Ellis BR; Barrett AD
Rev Med Virol; 2008; 18(5):331-46. PubMed ID: 18615782
[TBL] [Abstract][Full Text] [Related]
6. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.
Barrett AD; Monath TP; Barban V; Niedrig M; Teuwen DE
Vaccine; 2007 Apr; 25(15):2758-65. PubMed ID: 17368349
[TBL] [Abstract][Full Text] [Related]
7. Yellow fever in Africa: public health impact and prospects for control in the 21st century.
Tomori O
Biomedica; 2002 Jun; 22(2):178-210. PubMed ID: 12152484
[TBL] [Abstract][Full Text] [Related]
8. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Staples JE; Gershman M; Fischer M;
MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
[TBL] [Abstract][Full Text] [Related]
9. Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.
Garske T; Van Kerkhove MD; Yactayo S; Ronveaux O; Lewis RF; Staples JE; Perea W; Ferguson NM;
PLoS Med; 2014 May; 11(5):e1001638. PubMed ID: 24800812
[TBL] [Abstract][Full Text] [Related]
10. The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia.
Kieffer A; Hoestlandt C; Gil-Rojas Y; Broban A; Castañeda-Cardona C; Rosselli D
Value Health Reg Issues; 2019 Dec; 20():60-65. PubMed ID: 30974312
[TBL] [Abstract][Full Text] [Related]
11. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
Monath TP; Nasidi A
Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
[TBL] [Abstract][Full Text] [Related]
12. The global burden of yellow fever.
Gaythorpe KA; Hamlet A; Jean K; Garkauskas Ramos D; Cibrelus L; Garske T; Ferguson N
Elife; 2021 Mar; 10():. PubMed ID: 33722340
[TBL] [Abstract][Full Text] [Related]
13. Re-Emergence of Yellow Fever in Brazil during 2016-2019: Challenges, Lessons Learned, and Perspectives.
de Oliveira Figueiredo P; Stoffella-Dutra AG; Barbosa Costa G; Silva de Oliveira J; Dourado Amaral C; Duarte Santos J; Soares Rocha KL; Araújo Júnior JP; Lacerda Nogueira M; Zazá Borges MA; Pereira Paglia A; Desiree LaBeaud A; Santos Abrahão J; Geessien Kroon E; Bretas de Oliveira D; Paiva Drumond B; de Souza Trindade G
Viruses; 2020 Oct; 12(11):. PubMed ID: 33143114
[TBL] [Abstract][Full Text] [Related]
14. Prevention of yellow fever in persons traveling to the tropics.
Monath TP; Cetron MS
Clin Infect Dis; 2002 May; 34(10):1369-78. PubMed ID: 11981733
[TBL] [Abstract][Full Text] [Related]
15. Global Risk and Elimination of Yellow Fever Epidemics.
Ndeffo-Mbah ML; Pandey A
J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
[TBL] [Abstract][Full Text] [Related]
16. Yellow fever vaccine: past, present and future.
Roukens AH; Visser LG
Expert Opin Biol Ther; 2008 Nov; 8(11):1787-95. PubMed ID: 18847312
[TBL] [Abstract][Full Text] [Related]
17. Yellow fever vaccine: an effective vaccine for travelers.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028
[TBL] [Abstract][Full Text] [Related]
18. Review of the risks and benefits of yellow fever vaccination including some new analyses.
Monath TP
Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
[TBL] [Abstract][Full Text] [Related]
19. Impact of yellow fever on the developing world.
Tomori O
Adv Virus Res; 1999; 53():5-34. PubMed ID: 10582093
[TBL] [Abstract][Full Text] [Related]
20. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
Sante; 2003; 13(4):215-23. PubMed ID: 15047438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
